Subject: HESA study on the reforms of the Patented Medicine Prices Review Board (PMPRB) Dear Honourable Members,Life Sciences Ontario (LSO) is a not-for-profit organization that represents and promotes Ontario’s vibrant and diverse life sciences sector. Members of LSO include life sciences companies, entrepreneurs, members of academia, and service providers from…
News
Toronto, Ontario – LSO remains concerned by today’s release of the final PMPRB guidelines implementing the federal government’s patented medicine price controls. The final guidelines create a highly risky and uncertain pathway for commercializing new medicines and vaccines in Canada. LSO President and CEO Jason Field wants to ask the…
Life Sciences Ontario remains deeply concerned about the federal government’s patented medicine price controls and their potential to undermine the life sciences sector’s efforts to support the health and well-being of Canadians and the economy, particularly during the unprecedented COVID-19 pandemic. There is a growing body of evidence showing that…
Toronto, Ontario – In a time when the world is facing unparalleled uncertainty surrounding COVID-19, it has become increasingly apparent how integral the life sciences sector is to our society. The life sciences sector is at the forefront globally in combating the spread and developing vaccines and treatments to slow the…
Canada has long been considered a top global jurisdiction for new medicine launches. However, recent federal drug price controls have cast doubts on whether Canada can maintain this status. To help inform and contribute to this discussion, Life Sciences Ontario commissioned IQVIA – a global leader in health data and…
Life Sciences Ontario applauds the federal government’s recent decision to delay the implementation of the Patented Medicines Regulations to January 1, 2021 as part of the response to the COVID-19 crisis. This measure will help the Canadian life sciences sector remain unwaveringly focused on developing vaccines, treatments, and other tools to fight…
LSO put out a call to our members requesting insights on how companies are working together to combat the rapid spread of the novel COVID-19 virus. Below are some examples of how we, as a community are helping to control the outbreak. Member Announcements Amgen Canada: Amgen will provide its…
To help measure the impacts of the federal government’s new price controls for patented medicines in Canada, Life Sciences Ontario commissioned Research Etc., an established Toronto research firm, to conduct an anonymous survey of pharmaceutical and other life sciences leaders. The survey, which drew on data from 46 respondents including leaders…
Vancouver, Canada – January 9, 2020: With a shared vision to be a catalyst for Canadian life sciences leading the world, adMare BioInnovations, Canada’s Global Life Sciences Venture (adMare), and Accel-Rx, Canada’s Health Sciences Accelerator (Accel-Rx), announced today they are bringing their respective capabilities and resources together under adMare to…
How AI, Machine Learning and Automation are Affecting the Life Sciences & Agriculture sectors Posted on: December 18, 2019 in Blogs | Career Insights Blogs | Life Science BlogsBy: Candice Tang, MSc. For most people, it’s hard not to go a day without AI, machine learning and automation affecting some aspect of our lives. This goes beyond…